Table 4.
Controls | TP53 mutation | KRAS2 mutation | CIMP+ | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|||||||||||||||
dbSNP ID | Common Name |
genotype | N | N | OR | 95% CI | Pb | N | OR | 95% CI | Pb | N | OR | 95% CI | Pb |
rs10889675 | 88413 C > A | CC | 583 | 172 | 1.00 | ref. | 103 | 1.00 | ref. | 34 | 1.00 | ref. | |||
CA or AA | 192 | 37 | 0.66 | (0.46–0.94) | 0.03 | 31 | 0.98 | (0.66–1.46) | 0.66 | 13 | 1.27 | (0.68–2.39) | 0.63 | ||
rs1884444 | Gln3His | Gln/Gln | 229 | 48 | 1.00 | ref. | 29 | 1.00 | ref. | 9 | 1.00 | ref. | |||
Gln/His | 370 | 125 | 1.51 | (1.07–2.13) | 65 | 1.24 | (0.80–1.93) | 24 | 1.46 | (0.68–3.12) | |||||
His/His | 176 | 36 | 0.86 | (0.55–1.34) | 0.89 | 40 | 1.75 | (1.08–2.83) | 0.03 | 14 | 1.92 | (0.83–4.42) | 0.10 | ||
rs7539625 | 38962 G > A | GG | 383 | 98 | 1.00 | ref. | 81 | 1.00 | ref. | 29 | 1.00 | ref. | |||
GA or AA | 390 | 111 | 1.22 | (0.92–1.61) | 0.47 | 53 | 0.65 | (0.46–0.92) | 0.02 | 18 | 0.63 | (0.35–1.12) | 0.10 | ||
rs7542081 | 69450 C > A | CC or CA | 662 | 189 | 1.00 | ref. | 115 | 1.00 | 42 | 1.00 | ref. | ||||
AA | 112 | 19 | 0.60 | (0.37–0.98) | 0.04 | 19 | 1.08 | (0.67–1.75) | 0.92 | 5 | 0.78 | (0.32–1.92) | 0.47 |
Adjusted for age, sex, center, race
P-value for trend; if dominant or recessive model, p-value for association is shown.